Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYSABRI vs UBROGEPANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TYSABRI vs UBROGEPANT: Safety Overview

Metric TYSABRI UBROGEPANT
Total FAERS Reports 8,210 2,531
Deaths Reported 156 49
Death Rate 1.9% 1.9%
Hospitalizations 1,256 145
Average Patient Age 46.4 yrs 49.2 yrs
% Female Patients N/A 83.6%
FDA Approval Date N/A Dec 23, 2019
Manufacturer N/A Allergan, Inc.
Route N/A ORAL
Marketing Status N/A Prescription